United by a drive to redesign the infrastructure, practice, and experience of medicine

Matt is the Vice President of Enterprise Partnerships at Redesign Health, where he connects health systems, payors, biopharma, governments and technology companies with Redesign's platform and portfolio. A career healthcare technology operator, he brings more than a decade of experience building and scaling go-to-market engines through early-stage, scale-up, and turnaround environments, with particular depth in healthcare data interoperability and integration. Previously, Matt was the Vice President of Sales and Marketing at Blockit, where he led the company's relaunch as Alluvium Health. Before that, he spent nearly nine years at Redox, healthcare's leading interoperability platform. Matt holds BBAs in Finance and Management from the University of Wisconsin-Madison.

Mike is a Managing Director of Venture Buyouts at Redesign Health. With nearly a decade of institutional private equity experience focused exclusively on healthcare investing, Mike brings deep experience sourcing, evaluating, executing, and supporting investments across the healthcare landscape. Previously, Mike was a Principal and Head of Healthcare Investing at Affinity Partners, a $4.5Bn+ global investment fund, after serving as a Vice President at Galen Partners, one of the longest-tenured healthcare-dedicated private equity firms in the country. Mike holds a B.S. in Biomedical Engineering from Duke University.

Pankaj is a Partner and General Manager at Redesign Health, leading the firm’s India investments. He brings nearly 15 years of experience in the Indian startup ecosystem as an early-stage operator and investor. Prior to Redesign Health, Pankaj was at Prime Venture Partners, where he focused on AI-native companies reimagining industries such as healthcare, consumer and future of work. Earlier in his career, he held leadership roles at category creating companies such as Swiggy, Rupeek, Urban Ladder. Pankaj holds an MBA from the Kellogg School of Management and a BE in Electrical Engineering from BITS Goa.

Patrick is a Managing Director of New Ventures at Redesign Health. His 15 year healthcare career spans investing, strategic partnerships, corporate strategy, and consulting. Prior to Redesign, Patrick oversaw Labcorp’s corporate venture fund, where he deployed ~$20M annually and managed $100M+ capital at work across 30+ portfolio companies. Patrick began his career as a life sciences strategy consultant at Putnam, focused on drug development and commercialization. Patrick holds an MBA from Duke’s Fuqua School of Business and a B.S. in Chemistry from Duke University.

Preston Tollinger is VP of Technology, AI Ventures at Redesign Health, where he leads the firm's technical investing practice. A repeat founder and technology leader with more than two decades in software and digital health, Preston has built and scaled products across health insurance, consumer, and civic technology. He was co-founder and CTO of Collective Health, which he helped grow into a leading employer health platform backed by Founders Fund, Google Ventures, and NEA, and earlier co-founded Cellfire, a mobile commerce company acquired by Catalina Marketing. Most recently, he served as Chief Product & Technology Officer at Chorus Innovations. Preston holds a BS in Computer Science from Carnegie Mellon University and began his career as a research engineer at NASA Ames.

Tom is the Head of Founder Strategy at Redesign Health. Tom is an organizational psychologist and talent analytics expert with over a decade of experience building applied behavioral science products and workforce assessments. Previously, Tom was the VP of People Strategy at Morning Consult and a lead People Scientist at Humu (Acquired). Tom holds a Ph.D. in Industrial-Organizational Psychology from the Florida Institute of Technology.

Travis is the Director of Talent at Redesign Health, where he leads talent strategy across internal hiring and the portfolio. His background spans executive search and talent acquisition in both agency and in-house settings. Prior to Redesign Health, Travis was a Client Director at Candidate Labs where he focused on GTM and technology hiring across the startup ecosystem. Travis holds an MBA from Boston College.

Varun is Vice President of Technology for AI Ventures at Redesign Health, where he leads technology strategy for Venture Buyouts. Previously, Varun served as Chief Architect for Healthcare and Life Sciences at Salesforce, leading data & AI initiatives and building agentic products for organizations serving hundreds of millions of patients. Varun also led technical diligence for partnerships and acquisitions representing more than $1.5 billion in cumulative value. Earlier in his career, Varun built a startup as Co-founder & CTO and helped raise nearly $100 million from investors including Goldman Sachs.

Adam Karp is a seasoned C-suite executive with a strong record of scaling businesses, accelerating growth, and building customer loyalty through the smart use of data, technology, and creativity. He was the co-founder and former CEO of Redesign’s first venture, Lively (now Jabra Enhance), which he led to a successful $100M+ exit in just three years. Adam has driven results in venture-backed, private-equity, and public-company environments, with leadership roles across Century 21 Real Estate, FreshDirect, Barnes & Noble, and 1stDibs. He currently serves as interim CEO of LXE Hearing.

Isaac Councill is a seasoned technology and operations leader with a rich blend of real-world and academic experience. He currently serves as Chief Operating Officer at Vanna Health. Before joining Vanna Health, Isaac played a pivotal role in shaping technology strategy and execution at Oscar Health, where he joined as one of the first engineers on the team and rose to Chief Technology Officer by the time Oscar went public. In previous roles, he has served as an engineer at Google and as a scientist at IBM Research. Isaac earned a Ph.D. in Information Sciences & Technology from Penn State University, where his focus was systems engineering and AI/NLP.

Jeff Alter leads Sound Physicians with a deep commitment to improving patient care. Focused on building a premier medical group, he ensures that the communities Sound serves receive high-quality, localized care. Previously, Jeff was the CEO of Summit Health, guiding one of the largest independent multispecialty and urgent care medical groups. He also served as Executive Vice President of Anthem Health Solutions and President of IngenioRx, managing clinical and network analytics for nearly 44 million lives. At UnitedHealthcare, Jeff was CEO of the commercial group, overseeing health benefits for nearly 30 million consumers, including Fortune 100 companies and military personnel in the TRICARE West Region. Jeff holds a Bachelor of Science in marketing and an MBA in finance from St. John’s University in New York. He serves on several nonprofit and for-profit boards, including The Long Island Association and St. John’s University. Jeff and his wife, Lisa, are proud parents of four children and reside on Long Island, N.Y.

Lou is Senior Advisor, General Atlantic since October 2023. President and Chief Executive Officer of the Hospital for Special Surgery (“HSS”), a leading academic medical center focused on musculoskeletal health, from October 2006 until his retirement in October 2023. Prior to joining HSS, Mr. Shapiro worked at Geisinger Health System from 2002 to 2006, serving in roles with increasing leadership scope and ultimately advancing to Executive Vice President and Chief Operating Officer of the Clinical Enterprise. He served as a senior healthcare expert and consultant at McKinsey & Co. from 1999 to 2002 and held positions in other hospitals and health systems from 1983 through 1999. Mr. Shapiro has a bachelor of science degree in psychology from the University of Pittsburgh and a master’s degree in health administration from the University of Pittsburgh Graduate School of Public Health. Mr. Shapiro also has extensive healthcare and nonprofit board service, including serving as a founding member of the board of directors of RightMove Health and as board chairman of the Greater New York Hospital Association.

Michelle Rider is a marketing and growth executive with experience scaling healthcare, technology, and consumer brands, including Amazon, Teladoc, MDLIVE, and Aetna. She has led growth and alignment strategies that increased market valuation and supported two companies through successful IPOs. Ms. Rider serves on the advisory board of 2-Flo Ventures, a bioscience-focused venture capital firm, and White Glove AI, a company focused on AI governance for municipalities and governments. She also serves as a strategic mentor with portfolio companies, helping early-stage companies navigate critical growth inflection points. Ms. Rider is currently working on her first book, Getting to Double-Digit Growth, which distills her decades of experience scaling companies across multiple sectors. She holds an MBA from Northwestern University's Kellogg School of Management.

Dr Alhamali is a passionate and forward-thinking Senior Executive. He has a multifaceted background in strategy, research, innovation, and digital transformation spanning diverse sectors including public, private, and third-sector organizations. With an illustrious career spanning over a decade, he has been instrumental in pioneering national initiatives, orchestrating corporate strategies, and fostering robust collaborations with international stakeholders. His proficiency centers on harnessing cutting-edge technology and innovation to propel business expansion, optimize operational efficiencies and champion the Sustainable Development Goals agenda. He also plays a pivotal role in advancing the Kingdom’s Vision 2030. Previous roles for Dr. Allhamali include Chairman of National Innovation & Sandbox, Chief Innovation Officer – SEHA Virtual Hospital, Ministry of Health, Saudi Arabia.

Ms. Yang is a proven board director and former C-suite executive with repeat record of scaling high-growth, high-impact businesses across public companies, entrepreneurial ventures, and large health systems. She currently serves on the boards of S&P 500 and growth companies, advising on long-term value creation, AI and cyber strategy, global risk, and C-suite leadership development. With deep expertise at the intersection of AI, cybersecurity, and digital transformation, she has held senior operating roles in four public companies and served under two U.S. Presidential Administrations. As General Manager of Amazon Web Services, Healthcare, she led AWS’s highest margin healthcare business to 70%+ YoY growth, doubling financial and operating targets by commercializing AI/ML platforms and deploying scalable cloud and data solutions across highly regulated healthcare markets. A Council on Foreign Relations life member, she has been named Top 30 AAPI Board Director (BoardProspect), Top 100 Most Influential in Healthcare (Modern Healthcare), and Top 10 Women of Influence (Fierce Healthcare).

Rakesh M. Suri, MD, DPhil. is a globally recognized thought leader and pioneering cardiac surgeon with expertise in heart valve disease, robotics, transcatheter technology and complex multivalve pathology. He is a leader who has spearheaded the development of innovative models of healthcare delivery, international enterprise growth and organizational transformation in pursuit of value at Mayo Clinic and Cleveland Clinic. He is currently Professor of Surgery at Oakland University William Beaumont School of Medicine and Director of Robotic Cardiac Surgery / Cardiovascular Innovation at Corewell Health. Dr. Suri served as the first President of International Operations at the Cleveland Clinic leading the international strategy and global business development efforts positioning the organization as One Cleveland Clinic in the United States and abroad. From 2017-2021, Dr. Suri led Cleveland Clinic Abu Dhabi as President and Chief Executive Officer and served as an Executive Team member of the Cleveland Clinic Enterprise. He oversaw the hospital’s strategy and effective operations as the first-ever U.S. multispecialty hospital to be replicated outside of North America with more than 6,000 caregivers from 85+ countries in partnership with stakeholder Mubadala, one of the world’s largest sovereign wealth funds. Under his leadership the hospital grew to nearly 500 beds; launched the UAE’s first multi-organ transplantation and living-related organ donation programs; and supported healthcare transformation in Abu Dhabi, and the region through education, research, innovation, and construction of a state-of-the-art Oncology tower. He led the team towards financial sustainability, improving revenue and decreasing costs while delivering outcomes that led to the hospital being ranked amongst Newsweek's top 150 hospitals globally. Dr. Suri was a consultant in the Division of Cardiovascular Surgery, Professor of Surgery and Chair of the Enterprise Robotic Practice at Mayo Clinic until 2015. His academic pursuits include contributions to more than 340 peer- reviewed journal articles and book chapters, greater than 15 patents and several FDA multicenter trials. He was the Director of the Cardiovascular Fellowship Program at Mayo Clinic and past President of the Heart Valve Society. Dr. Suri earned his undergraduate degree at Queen’s University in Kingston, Ontario, Canada, medical degree with honors from the University of Toronto and a doctorate at Magdalen College, Oxford, UK, as a Rhodes Scholar. He completed thoracic surgical residency at Mayo Clinic College of Medicine and is board-certified in both General Surgery and Cardiothoracic Surgery.